The detection of heterozygous familial hypercholesterolemia in Ireland

Advances in Therapy

Volumn 29, Issue 5, 2012, Pages 456-463

  O'Kane, Maurice J ^a   Menown, Ian B ^b   Graham, Ian ^c   Maher, Vincent ^d   Tomkin, Gerald ^e   Nicholls, Paul ^f   Graham, Colin ^g  

^a ALTNAGELVIN HOSPITAL   (United Kingdom)

^b SOUTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^c Charlemont Clinic   (Ireland)

^d ADELAIDE AND MEATH HOSPITAL   (Ireland)

^e TRINITY COLLEGE DUBLIN   (Ireland)

^f ROYAL VICTORIA HOSPITAL   (United Kingdom)

^g BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Detection; Familial hypercholesterolemia; Ireland; Lipid clinics; Primary healthcare; Screening

Indexed keywords

APOLIPOPROTEIN B100; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANAMNESIS; APOLIPOPROTEIN B100 GENE; ARTICLE; DATA BASE; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; GENE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; IRELAND; LOW DENSITY LIPOPROTEIN RECEPTOR GENE; MASS SCREENING; MORBIDITY; MORTALITY; PHYSICAL EXAMINATION; PREVALENCE; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 GENE; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

CHOLESTEROL, LDL; DATABASES, FACTUAL; EARLY DIAGNOSIS; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; IRELAND; MASS SCREENING; MOLECULAR DIAGNOSTIC TECHNIQUES; NORTHERN IRELAND;

EID: 84863723787     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-012-0021-0     Document Type: Article

References (22)

1. Northern Ireland Statistics and Research Agency. Registrar General Annual Report 2009. Belfast 2010. Available at: http://www.nisra.gov.uk/publications/ archive/NISRA-Annual-Report-20089.pdf. Accessed Jan 5 2012.
2. Ireland and Northern Ireland Public Health Observatory (INIsPHO). Preliminary estimates and forecasts of the population prevalence of selfreported hypertension, ischaemic heart disease and stroke in the Republic of Ireland from 2005-2015. Available at: www.publichealth.ie. Accessed Jul 11 2011.
3. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolaemia. In: Scriver CR, Sly WS, Childs B, et al., eds. The Metabolic and Molecular Basis of Inherited Disease. New York, NY: McGraw-Hill Companies; 2001:2863-94.
4. NICE. Identification and management of familial hypercholesterolaemia. NICE Clinical Guideline 71. Available at: www.nice.org.uk/CG071. Accessed Jan 6 2012.
5. Humphries SE, Whittall RA, Hubbart CS, et al. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet. 2006;43:943-9. (Pubitemid 46080192)
6. O'Neill FH, Patel DD, Knight BL, et al. Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolaemia. Arterioscler Thromb Vasc Biol. 2001;21:832-7. (Pubitemid 32448775)
7. Marks D, Thorogood M, Neil HA, Humphries SE. A review on the diagnosis, natural history and treatment of familial hypercholesterolaemia. Atherosclerosis. 2003;168:1-14. (Pubitemid 36559596)
8. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ. 1991;302:893-6.
9. World Health Organization. Familial hypercholesterolaemia [FH]: Report of a second WHO consultation. Geneva: World Health Organization. 1999. Available at: www.who.int/entity/genomics/publications/reports/en/.Accessed Dec 21 2012.
10. Williams RR, Hunt SC, Schumacher MC, et al. Diagnosing heterozygous familial hypercholesterolaemia using new practical criteria validated by molecular genetics. Am J Cardiol. 1993;72:171-6. (Pubitemid 23205873)
11. European Association for Cardiovascular Prevention and Rehabilitation; Reiner Z, Catapano AL, De Backer G. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology [ESC] and the European Atherosclerosis Society [EAS]. Eur Heart J. 2011;32:1769-818.
12. Koivunen-Niemelä T, Alanen A, Viikari J. Sonography of the Achilles tendon in hypercholesterolaemia. J Intern Med. 1993;234:401-5. (Pubitemid 23305789)
13. Graham CA, McIlhatton BP, Kirk CW, et al. Genetic screening protocol for familial hypercholesterolaemia which includes spicing defects gives an improved mutation rate detection rate. Atherosclerosis. 2005;182:331-40. (Pubitemid 41267202)
14. Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolaemia: a HuGE prevalence review. Am J Epidemiol. 2004;160:407-20. (Pubitemid 39166973)
15. Damgaard D, Larsen ML, Nissen PH, et al. The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolaemia in a Danish population. Atherosclerosis. 2005;180:155-60.
16. Wilson JMG, Jungner G. Principles and practice for the screening of disease. WHO Chronicle. 1968;22:473.
17. Gray J, Jaiyeola A, Whiting M, et al. Identifying patient with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart. 2008;94:754-8. (Pubitemid 351744695)
18. Starr B, Hadfield SG, Hutten BA, et al. Development of sensitive and specific age-and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade screening. Clin Chem Lab Med. 2008;46:791-803. (Pubitemid 351821631)
19. Defesche JC, Lansberg Pj, Umans-Eckenhausen MA, Kastelein JJ. Advanced method for the identification of patients with inherited hypercholesterolaemia. Semin Vasc Med. 2004;4:59-65. (Pubitemid 38393292)
20. Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, et al. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357:165-8. (Pubitemid 32108086)
21. Marks D, Thorogood M, Neill SM, Humphries SE, Neil HA. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes. J Med Screen. 2006;13:156-9. (Pubitemid 44452729)
22. Bhatnagar D, Morgan J, Siddiq S, Mackness MI, Miller JP, Durrington PN. Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. BMJ. 2000;321:1497-500. (Pubitemid 32011368)